Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 28 of the 63 sources its claims cite were checked for support.

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip

Open access
Kim, Hyun Jung, Li, Hu, Collins, James J., Ingber, Donald E.·2016·Proceedings of the National Academy of Sciences

Abstract

Significance: The main advance of this study is the development of a microengineered model of human intestinal inflammation and bacterial overgrowth that permits analysis of individual contributors to the pathophysiology of intestinal diseases, such as ileus and inflammatory bowel disease, over a period of weeks in vitro. By studying living human intestinal epithelium, with or without vascular and lymphatic endothelium, immune cells, and mechanical deformation, as well as living microbiome and pathogenic microbes, we identified previously unknown contributions of specific cytokines, mechanical motions, and microbiome to intestinal inflammation, bacterial overgrowth, and control of barrier function. We provide proof-of-principle to show that the microfluidic gut-on-a-chip device can be used to create human intestinal disease models and gain new insights into gut pathophysiology.

Overview

CoChat Summary

TL;DR

A human gut-on-a-chip was used to coculture intestinal epithelial cells with commensal microbes, immune cells, and peristalsis-like mechanical deformation for over a week. The model showed that immune cells plus LPS or nonpathogenic *E. coli* drive a four-cytokine injury response, and that loss of mechanical deformation alone triggers bacterial overgrowth.

Key findings

  • Caco-2 cells on-chip formed villi and had a transcriptome distinct from static Transwell cultures across 22,097 genes (P < 0.00001); coculture with VSL#3 probiotics shifted them closer to normal human ileum (P < 0.00001).
  • LPS (15 μg/mL) or GFP-*E. coli* alone did not disrupt barrier function or induce cytokines, but with PBMCs they caused significant barrier loss and villus destruction; EIEC alone destroyed barrier and villus architecture within 24–36 h, and PBMCs accelerated/exacerbated injury.
  • IL-1β, IL-6, IL-8, and TNF-α together were necessary and sufficient to induce villus injury; anti-IL-8 monoclonal antibody completely prevented injury, while IL-8 alone was not sufficient.
  • Removing cyclic mechanical deformation while maintaining luminal flow more than doubled GFP-*E. coli* density within 21 h versus stretched chips (P < 0.001); VSL#3 increased TEER by >50% (P < 0.001), reduced EIEC injury (P < 0.01), and delayed injury onset by ~18 h.

Methods

  • PDMS gut-on-a-chip with upper/lower microchannels separated by a porous ECM-coated membrane; Caco-2BBE intestinal epithelial cells were cultured under flow (30 μL/h; 0.02 dyne/cm²) and cyclic deformation (10% strain, 0.15 Hz), forming villi after ~100 h.
  • Coculture experiments used VSL#3 probiotics, GFP-*E. coli*, enteroinvasive *E. coli* (EIEC), LPS (15 μg/mL), human PBMCs, and endothelial cells; antibiotics tested were 100 units/mL penicillin plus 100 μg/mL streptomycin.
  • Analyses included TEER, phase/confocal microscopy, cytokine measurements, qPCR, and Affymetrix Human Genome 1.0 ST microarrays compared with GEO normal small intestine data; statistics used one-way ANOVA with Tukey-Kramer, P < 0.05, and mean ± SEM.

Limitations

  • Stated in the paper: Caco-2 cells originated from a human colorectal tumor; VSL#3 is not fully representative of the complex normal gut microbiome; the antibiotics used differ from those most common in the clinic; PBMCs are a mixed immune population and do not include all gut immune components; species-level population dynamics were not analyzed.
  • Evident from the text: this is an in vitro synthetic microdevice, not human or animal in vivo, so findings require validation in more complex systems; the model uses a minimal set of cell types and microbial strains, and the authors note it could be improved with primary/iPS-derived epithelium, connective tissue, immune subsets, and more complex patient-derived microbial communities.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1522193112

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

17 Valid · 3 Not valid · 19 Not checked · 88 Own results and interpretations

67 more claims

Create a free account to see all 127 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 42

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 64 references

Cited by

See all 922

Metadata

Authors
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E.
Affiliations
  • Harvard University (US)
  • Broad Institute (US)
  • Boston Children's Hospital (US)
Corresponding author
Ingber, Donald E.
Venue
Proceedings of the National Academy of Sciences
Published
2015-12-14
Volume
113
Issue
1
Pages
E7-15
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2214747519
Cited by
922
References
64
Citations by year
2026: 32 · 2025: 67 · 2024: 101 · 2023: 90 · 2022: 98 · 2021: 146 · 2020: 117 · 2019: 78 · 2018: 88 · 2017: 73 · 2016: 31
FWCI
22.15
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders
  • Harvard University
  • Hamilton Health Sciences Foundation
  • U.S. Food and Drug Administration (HHSF223201310079C)
  • Defense Advanced Research Projects Agency (W911NF-12-2-0036)
  • Advanced Research Projects Agency
  • Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
gut-on-a-chip, intestinal bacterial overgrowth, intestinal inflammation, gut microbiota, mechanical deformation, peristalsis, intestinal epithelial cells, intestinal barrier function, inflammatory cytokines, lipopolysaccharide, inflammatory bowel disease, ileus, probiotics, antibiotics, commensal microorganisms, co-culture model
MeSH terms
Animals, Anti-Bacterial Agents, Bacteria, Humans, Intestinal Mucosa, Models, Biological, Peristalsis, Tumor Necrosis Factor-alpha, Inflammatory Bowel Diseases, Interleukin-6, Interleukin-8, Caco-2 Cells, Probiotics, Ileus, Interleukin-1beta, Lab-On-A-Chip Devices, Microbiota, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. https://app.cochat.ai/papers/10.1073/pnas.1522193112
The paper
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016). Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1522193112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.